Irrefutable evidence for the use of docetaxel in newly diagnosed metastatic prostate cancer: results from the STAMPEDE and CHAARTED trials
Crossref DOI link: https://doi.org/10.1186/s12916-015-0543-9
Published Online: 2015-12-22
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van Soest, Robert J.
de Wit, Ronald
License valid from 2015-12-01